Author(s): Brazzelli V, Barbagallo T, Prestinari F, Vassallo C, Agozzino M,
Abstract Share this page
Abstract The treatment of vitiligo is still a challenge. Among various therapeutic modalities, phototherapy with UVB narrowband (UVB-NB) is presently considered a treatment of choice for this skin disease. The exact skin cancer risk deriving from UVB-NB is a serious concern to be determined. We report a case of keratoacanthoma developed in the vitiligo area during a prolonged course of UVB-NB therapy.
This article was published in Photodermatol Photoimmunol Photomed
and referenced in Journal of Clinical & Experimental Dermatology Research